secwatch / observer
8-K filed March 28, 2025, 7:59 PM ET ticker IAC CIK 0001800227
other material confidence high sentiment neutral materiality 0.85

IAC completes spin-off of Angi; 0.5251 shares per IAC share on March 31, 2025

IAC Inc.

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001104659-25-029063
form_type
8-K
ticker
IAC
cik
0001800227
company_name
IAC Inc.
filed_at
2025-03-28T23:59:59+00:00
discovered_at
2026-05-14T18:03:04.916478+00:00
generated_at
2026-05-24T03:12:27.951985+00:00
sec_items
["7.01"]
event_type
other_material
sentiment
neutral
materiality_score
0.85
calibrated_materiality_score
0.85
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001104659-25-029063
json_url
https://secwatch.observer/filing/0001104659-25-029063.json
markdown_url
https://secwatch.observer/filing/0001104659-25-029063.md
text_url
https://secwatch.observer/filing/0001104659-25-029063.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1800227/000110465925029063/0001104659-25-029063-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1800227/000110465925029063/tm2510759d1_8k.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null

Comparable filings

AII

American Integrity fully places 2026-2027 CAT XOL reinsurance with $2.99B total limit

American Integrity Insurance Group, Inc. June 1, 2026, 4:31 PM ET other_material Items 7.01, 9.01

same SEC item: 7.01 same event type: other_material similar materiality

Filing page SEC filing

CSR

Centerspace approves $240-245M asset sales; exits Bismarck and Rapid City

CENTERSPACE June 1, 2026, 4:30 PM ET other_material Items 7.01, 8.01, 9.01

same SEC item: 7.01 same event type: other_material similar materiality

Filing page SEC filing

LBTYA

Liberty Global names Stephen van Rooyen as Ziggo Group CEO; plans Amsterdam listing in 2027

Liberty Global Ltd. June 1, 2026, 4:07 PM ET other_material Items 7.01, 9.01

same SEC item: 7.01 same event type: other_material similar materiality

Filing page SEC filing

IDYA

IDEAYA's darovasertib combo meets primary endpoint in Phase 2/3 OptimUM-02 trial for metastatic uveal melanoma

IDEAYA Biosciences, Inc. June 1, 2026, 4:05 PM ET other_material Items 7.01, 8.01, 9.01

same SEC item: 7.01 same event type: other_material similar materiality

Filing page SEC filing

MDAI

Spectral AI gets FDA clearance for DeepView burn indication; targets first commercial sales by year-end 2026

Spectral AI, Inc. June 1, 2026, 4:01 PM ET other_material Items 5.07, 7.01, 9.01

same SEC item: 7.01 same event type: other_material similar materiality

Filing page SEC filing

LIXT

Lixte Biotechnology pivots to AI energy infrastructure; appoints Denham Capital founder to board

LIXTE BIOTECHNOLOGY HOLDINGS, INC. June 1, 2026, 8:55 AM ET other_material Items 5.02, 7.01, 9.01

same SEC item: 7.01 same event type: other_material similar materiality

Filing page SEC filing

TTRX

Turn Therapeutics GX-03 Phase 2 interim: 92.6% EASI-50 at 4 weeks; no SAEs

Turn Therapeutics Inc. June 1, 2026, 8:45 AM ET other_material Items 7.01, 9.01

same SEC item: 7.01 same event type: other_material similar materiality

Filing page SEC filing

OPTU

Optimum raises $500M via preferred units, starts $300M tender at $2.50 to shield assets from CSC debt

Optimum Communications, Inc. June 1, 2026, 8:16 AM ET other_material Items 1.01, 3.02, 7.01, 8.01, 9.01

same SEC item: 7.01 same event type: other_material similar materiality

Filing page SEC filing

Source: SEC EDGAR
accession 0001104659-25-029063

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.